Detalhe da pesquisa
1.
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
Leuk Lymphoma
; 48(7): 1290-8, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17613756